Lv1
20 积分 2023-05-11 加入
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
15天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
17天前
已完结
Small-molecule BTK inhibitors: From discovery to clinical application
1个月前
已完结
Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
1个月前
已完结
Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta‐Analysis
1个月前
已完结
Pirtobrutinib: First Approval
1个月前
已完结
The Src, Syk, and Tec family kinases: Distinct types of molecular switches
1个月前
已完结
Faculty Opinions recommendation of BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation
1个月前
已关闭
Non-Hodgkin lymphoma
1个月前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
1个月前
已完结
皖公网安备34019202002308
